AWM
TMO icon

Affinity Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Affinity Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
859
+1
+0.1% +$480 0.06% 68
2026
Q1 		$422K Buy
858
+1
+0.1% +$543 0.06% 62
2025
Q4 		$497K Buy
857
+4
+0.5% +$2.26K 0.07% 61
2025
Q3 		$414K Buy
853
+1
+0.1% +$465 0.06% 65
2025
Q2 		$345K Buy
852
+1
+0.1% +$418 0.06% 71
2025
Q1 		$423K Sell
851
-5
-0.6% -$2.71K 0.08% 61
2024
Q4 		$446K Buy
856
+6
+0.7% +$3.3K 0.08% 62
2024
Q3 		$526K Sell
850
-3
-0.4% -$1.78K 0.09% 60
2024
Q2 		$472K Hold
853
– – 0.09% 60
2024
Q1 		$496K Sell
853
-27
-3% -$15.2K 0.09% 58
2023
Q4 		$467K Hold
880
– – 0.1% 60
2023
Q3 		$445K Buy
880
+1
+0.1% +$533 0.1% 61
2023
Q2 		$459K Buy
879
+33
+4% +$17.8K 0.11% 64
2023
Q1 		$488K Hold
846
– – 0.11% 65
2022
Q4 		$466K Hold
846
– – 0.11% 56
2022
Q3 		$429K Hold
846
– – 0.11% 58
2022
Q2 		$469K Hold
846
– – 0.11% 60
2022
Q1 		$487K Hold
846
– – 0.1% 60
2021
Q4 		$502K Sell
846
-5
-0.6% -$3.12K 0.1% 66
2021
Q3 		$482K Hold
851
– – 0.09% 70
2021
Q2 		$438K Sell
851
-185
-18% -$87.3K 0.09% 67
2021
Q1 		$505K Hold
1,036
– – 0.1% 61
2020
Q4 		$526K Buy
1,036
+185
+22% +$86.7K 0.11% 62
2020
Q3 		$386K Hold
851
– – 0.1% 57
2020
Q2 		$352K Hold
851
– – 0.44% 36
2020
Q1 		$281K Sell
851
-5,761
-87% -$1.82M 0.17% 40
2019
Q4 		$2.15M Buy
6,612
+401
+6% +$122K 0.8% 19
2019
Q3 		$1.81M Buy
6,211
+158
+3% +$45.2K 0.73% 23
2019
Q2 		$1.78M Buy
6,053
+94
+2% +$25.9K 0.7% 21
2019
Q1 		$1.63M Buy
5,959
+174
+3% +$43.3K 0.65% 23
2018
Q4 		$1.29M Buy
+5,785
New +$1.36M 0.78% 23

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Affinity Wealth Management's TMO Position: Q2 2026 in Review

Affinity Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.12% in Q2 2026, buying an estimated $480 and bringing the position to 859 shares worth $431K. The position accounts for 0.06% of the portfolio, ranked #68.

Affinity Wealth Management first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.15M in Q4 2019. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Affinity Wealth Management held 859 shares of Thermo Fisher Scientific worth $431K as of Q2 2026.
  • Affinity Wealth Management bought 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.06% of Affinity Wealth Management's portfolio in Q2 2026, its #68 holding.
  • Affinity Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • Affinity Wealth Management's Thermo Fisher Scientific position peaked at $2.15M in Q4 2019.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Affinity Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.